DCF for early-stage Indian companies: why terminal value always dominates

Most of the DCF models we review for fundraises, ESOP valuations, and 56(2)(x) compliance share a common structural problem. The founder or their advisor has built an immaculate five-year projection. Revenue grows from Rs. 8 crore in year one to Rs. 75 crore in year five. EBITDA margins expand from negative twelve percent to plus eighteen percent. Working capital is modelled. Capex is modelled. The model is detailed.

Then there is a single line at the bottom: terminal value, calculated as year-five free cash flow times an exit multiple of ten. That one line is 78 percent of the enterprise value the model spits out.

Almost every acquirer's diligence team and every experienced merchant banker knows to scrutinize that one line first. The five-year projection above it is a sanity check, not the answer. We have learned to build models that acknowledge this honestly, and to negotiate with the assumptions that actually move the number.

The arithmetic of horizon length

For a young Indian company growing 60-100 percent in its early years, the explicit-period horizon is typically five to seven years. That sounds long. It is not.

Consider a company whose free cash flow profile is negative in year one, breaks even in year three, and reaches Rs. 14 crore in year five. Discounted at a 22 percent rate of return appropriate for a Series A Indian SaaS company, the present value of the explicit-period cash flows sums to roughly Rs. 11 crore. If the terminal value at year five is calculated using an exit EV/EBITDA multiple of 12x against a year-five EBITDA of Rs. 18 crore, the terminal value is Rs. 216 crore. Discounted back five years at 22 percent, that is Rs. 81 crore.

Enterprise value: Rs. 92 crore. Terminal value share: 88 percent.

This is not a modelling defect. It is mathematics. Any business whose value is concentrated in cash flows after year five will produce a DCF where the terminal value dominates. For early-stage companies, that is structurally true. The cash flows in years one through five are too small to carry the valuation. The interesting cash flows arrive later.

What the explicit period is actually for

If terminal value is doing 75-85 percent of the work, why bother modelling the explicit period at all? Because the year-five EBITDA and revenue numbers that feed the terminal calculation come from the explicit period. The model is not pointless; it is just that the only line items that matter in the output are the year-five EBITDA, the chosen exit multiple, and the perpetuity growth rate if you are using a Gordon Growth tail instead of a multiple.

We build the explicit period rigorously, but we are honest about what it produces. The explicit period is a structured argument for the year-five steady-state numbers. The terminal value is a structured argument for what the world looks like beyond that.

Indian risk-free rate, equity risk premium, size premium

The discount rate for an Indian private-company DCF cannot be lifted from a US 409A. Each component has to be Indian.

Risk-free rate. The 10-year Government of India bond yield, currently in the range of 6.9-7.2 percent, is the standard reference. The 30-year G-Sec is occasionally used for long-duration assets but is thinly traded; the 10-year is the conventional choice.

Equity risk premium. For India, the long-run equity risk premium sits in the 5-6 percent range. This is the additional return investors require above the risk-free rate for equity exposure in Indian listed markets. Aswath Damodaran's country risk premium tables are a useful cross-check.

Size premium. A small-stock premium of 3-4 percent on top of the levered cost of equity is defensible for companies with revenue below Rs. 100 crore. Below Rs. 25 crore, a 4-5 percent premium is not aggressive.

Company-specific risk premium. For pre-product-market-fit or single-customer-concentrated businesses, an additional 2-4 percent is appropriate. This is the line that gets challenged most often; document the rationale.

Add the components: 7 percent risk-free, 5.5 percent equity risk premium times a sector beta of 1.2 (equals 6.6 percent), 3.5 percent size premium, 3 percent company-specific risk. Total cost of equity: 20.1 percent. For an early-stage company with little debt, this is also the WACC. A discount rate in the 20-25 percent range is the defensible band for most Series A to Series C Indian companies.

The two assumptions that swing valuation 30-50 percent

Once the cost of equity is set, the two terminal-value assumptions do almost all of the rest of the work.

Exit multiple

If you are using an EV/EBITDA exit multiple, the choice between 8x and 12x changes the terminal value by 50 percent. That is the same swing as the difference between a base-case and bull-case valuation. The exit multiple cannot be a number plucked from a slide deck. It has to be anchored to listed-comparable trading multiples adjusted for India and stage, or to recent acquisition multiples for similar-stage assets.

We pull median EV/EBITDA multiples for the company's listed peer group from Bloomberg or CapitalIQ, take the trailing three-year median rather than the spot multiple to avoid frothy or distressed snapshots, and apply a private-company discount of 20-30 percent. For a sector where listed peers trade at 18x trailing EBITDA, the defensible exit multiple for a private comparable is 13-14x. Not 18x.

Perpetuity growth rate

If you are using a Gordon Growth terminal value instead of an exit multiple, the perpetuity growth rate is even more sensitive. A change from 2 percent to 4 percent on a discount rate of 22 percent changes terminal value by roughly 12 percent. On a discount rate of 14 percent, the same change moves terminal value by 30 percent.

The perpetuity growth rate cannot exceed the long-run nominal GDP growth rate of the economy. For India that ceiling is around 11-12 percent (real growth plus inflation), and the conservative number used by serious analysts is 3-5 percent. A 6 percent perpetuity growth rate for an Indian company has to be defended with explicit reference to long-run sector economics.

Why auditors and acquirers go straight to terminal value

When we sit on the other side of the table reviewing a counterparty's DCF, we spend ninety percent of our review time on three numbers: the discount rate, the exit multiple or perpetuity growth, and the year-five EBITDA margin. We barely look at year-two revenue growth.

This is not laziness. It is because the explicit-period revenue is the easiest number for a founder to defend with a story about pipeline and product roadmap, and the hardest number for an external reviewer to challenge in the absence of operating history. The terminal-value assumptions, by contrast, are testable against market data. Listed-peer multiples are public. G-Sec yields are public. The size premium has academic precedent.

A DCF that hides aggressive terminal-value assumptions behind a beautifully detailed explicit period is the classic founder move. Sophisticated reviewers see through it instantly.

Sensitivity tables you should always include

A defensible valuation report has at minimum a two-by-two sensitivity table on the two terminal-value drivers (discount rate and exit multiple, or discount rate and perpetuity growth). For Rule 11UA-compliant valuations under the Income Tax Rules, we usually include both. The table shows the enterprise value across at least three discount-rate scenarios and three terminal-assumption scenarios.

When the sensitivity table reveals that the central-case valuation can swing by 40-60 percent across the realistic range of inputs, the right honesty is to present the central case as a point estimate within a range, not as a precise number. We say things like, 'the DCF supports an enterprise value range of Rs. 80-130 crore with a central estimate of Rs. 102 crore.' That is a defensible statement. 'The company is worth Rs. 102 crore' is not.

What this means for negotiation

If you are a founder going into a fundraise or an acquisition discussion, knowing that terminal value dominates changes how you negotiate. The buyer's pushback will come on the exit multiple and the discount rate. Those are where you need your evidence ready: listed-peer trading multiples, transaction comparables, sector-specific WACC studies.

The buyer who tries to chip away at your year-three revenue assumption is wasting their leverage. The buyer who pushes back on a 12x exit multiple when listed peers trade at 14x is asking the right question. Be ready for the second conversation.